uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Cancer: antitumor effects of octreotide LAR, a somatostatin analog
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Internal Medicine. (Kjell l Öberg)
2010 (English)In: Nature reviews. Endocrinology, ISSN 1759-5029, Vol. 6, no 4, 188-189 p.Article in journal (Refereed) Published
Abstract [en]

Treatment of nonfunctioning neuroendocrine tumors with somatostatin analogs has been controversial, given the low antitumor effects of these drugs. The ProMid study group now reports that octreotide lar (long-acting release) has a substantial antitumor effect, with longer progression-free survival compared with placebo in patients with well-differentiated neuroendocrine tumors and low tumor burden.

Place, publisher, year, edition, pages
2010. Vol. 6, no 4, 188-189 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-129580DOI: 10.1038/nrendo.2010.3ISI: 000275959300003PubMedID: 20336162OAI: oai:DiVA.org:uu-129580DiVA: diva2:344362
Available from: 2010-08-19 Created: 2010-08-19 Last updated: 2010-09-22Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Internal Medicine
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 105 hits
ReferencesLink to record
Permanent link

Direct link